A Phase III Randomized, Double-Blind Study of Maintenance Therapy with CC-5013 (NSC # 703813, IND # 70116) or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma
Clinical Professor, Pete and Carolyn Newsome Urologic Oncology Professorship, David A. Cofrin Endowed Chair Of Urologic Oncology, and Associate Director Of Clinical Research, Uf Health Cancer Center
